1
Discover top-quality products tailored for scientific and medical research. Request a personalized quote today
to enhance your projects.
| Species | Human |
| Cat.No | ABC-SC213Y |
| Quality Control | All cells test negative for mycoplasma, bacteria, yeast, and fungi. |
| Product Category | Stem Cells |
| Size/Quantity | 1 vial |
| Cell Type | Induced Pluripotent Stem Cell |
| Shipping Info | Dry Ice |
| Growth Conditions | 37℃, 5% CO2 |
| Source Organ | Human Skin Fibroblast |
| Disease | Normal |
| Biosafety Level | 1 |
| Storage | Liquid Nitrogen |
| Product Type | Human iPSCs |
HighQC™ Human iPSC Line (Retroviral, Fibroblast) is a human induced pluripotent stem cell (iPSC) line generated through retroviral-based reprogramming technology. This approach uses retroviruses to introduce key reprogramming factors (such as OCT4, SOX2, KLF4, and c-MYC) into adult fibroblasts, reprogramming them into a pluripotent state. The resulting iPSCs exhibit typical pluripotent characteristics, including the ability to form embryoid bodies and express pluripotency markers such as OCT4, SOX2, NANOG, and SSEA-4. The retroviral method involves the integration of reprogramming factors into the host genome, which can present both advantages in terms of efficiency and challenges in long-term genetic stability. HighQC™ Human iPSC Line (Retroviral, Fibroblast) is suitable for a variety of applications, including disease modeling, drug discovery, and cell-based therapies.
When you publish your research, please cite our product as “AcceGen Biotech Cat.# XXX-0000”. In return, we’ll give you a $100 coupon. Simply click here and submit your paper’s PubMed ID (PMID).
HighQC™ Human iPSC Line (Retroviral, Fibroblast) is ideal for disease modeling, drug discovery, and regenerative medicine. This cell line offers a stable reprogramming process and is widely applied in various disease studies. Example applications include creating patient-specific models for breast cancer or leukemia, testing the efficacy of new cancer therapies, or developing cell-based therapies for heart disease, diabetes, and other conditions.